Ayr Strategies (OTCMKTS:AYRSF) and TerrAscend (OTCMKTS:TRSSF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.
Earnings and Valuation
This table compares Ayr Strategies and TerrAscend's gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Ayr Strategies | N/A | N/A | N/A | N/A | N/A |
TerrAscend | N/A | N/A | N/A | N/A | N/A |
Profitability
This table compares Ayr Strategies and TerrAscend's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Ayr Strategies | N/A | N/A | N/A |
TerrAscend | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of recent recommendations for Ayr Strategies and TerrAscend, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Ayr Strategies | 0 | 1 | 6 | 0 | 2.86 |
TerrAscend | 0 | 0 | 7 | 0 | 3.00 |
Ayr Strategies currently has a consensus target price of $34.8571, suggesting a potential upside of 63.96%. TerrAscend has a consensus target price of $18.5417, suggesting a potential upside of 86.35%. Given TerrAscend's stronger consensus rating and higher possible upside, analysts plainly believe TerrAscend is more favorable than Ayr Strategies.
Summary
TerrAscend beats Ayr Strategies on 3 of the 3 factors compared between the two stocks.